Purchase Order HHSN272201600262P
Award Date 1/21/16
Potential Completion Date 7/19/16
Potential Value $9.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Bioreliance Corporation for endotoxin and sterility testing services. The $16,051.00 firm fixed price contract does not have a set-aside designation, indicating Bioreliance's competitive standing in the field of pharmaceutical and biotechnology research and development. As a foreign-owned, for-profit organization,...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15,434.00 firm-fixed-price purchase order to Bioreliance Corporation, a foreign-owned for-profit organization, for endotoxin and sterility testing services. The contract has an ultimate completion date of September 8, 2025. Bioreliance, through its Life Sciences Services division, provides specialized microbiological examination, bioburden...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract valued at $15,434.00 to Bioreliance Corporation, a foreign-owned for-profit organization. The contract is for endotoxin and sterility testing services to support investigational new drug applications. Bioreliance Corporation, through its Life Sciences Services division doing business as Bioreliance...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Bioreliance Corporation, a foreign-owned, for-profit organization doing business as Bioreliance Corp De. The $39,085.34 firm fixed-price delivery order contract is for Bioreliance to provide a range of specialized testing services, including endotoxin, sterility, and general safety testing, in support of investigational new drug...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services (HHS), to Bioreliance Corporation, a foreign-owned, for-profit organization specializing in critical testing services for the pharmaceutical and biotechnology industries. The $4,930.00 firm fixed-price purchase order is for Bioreliance's cell bank storage and other related functions. This award is not designated as a...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization. The $88,338.85 firm fixed-price delivery order contract is for sterility testing services, including endotoxin, general safety, and microbiological examination testing to support investigational new drug applications. Bioreliance has a long history of providing these services to...
- The Department of Health and Human Services National Institutes of Health (NIH) National Cancer Institute awarded a $80,848.00 Delivery Order contract to Bioreliance Corporation, a foreign-owned for-profit organization, for sterility testing services. The contract is for endotoxin, sterility, and general safety testing to support investigational new drug applications. Bioreliance has a history of providing these types of testing services to the NIH National Institute of Allergy and Infectious...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization, for the delivery of sterility units. The $9,630.86 firm fixed-price contract is a delivery order with a completion date of June 30, 2013. Bioreliance Corporation's Life Sciences Services division, doing business as Bioreliance Corp De, has extensively supported HHS and NIH...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,561.00 firm fixed price purchase order contract to Bioreliance Corporation, a foreign-owned for-profit company, to provide endotoxin, sterility, and general safety testing services in support of investigational new drug applications. The contract includes isolator sterility testing using direct inoculation methods, LAL testing for...
- This is a Delivery Order award by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization. The $35,018.20 Firm Fixed Price contract is for Other Functions Package 2, Line Item 88 - Sterility Units, Catalog #510120GMP.BSV. No set-aside designation was used. Bioreliance Corporation provides endotoxin, sterility, and general safety testing services through its Life Sciences...